Pharma-Bio Serv, Inc. (PBSV)

Pharma-Bio Serv Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Market Capitalization	11	12	13	20	20	24
Market Cap Growth	-36.87%	-7.06%	-31.76%	-1.11%	-16.81%	-20.06%
Enterprise Value	1	2	1	5	6	8
Last Close Price	0.50	0.47	0.44	0.60	0.57	0.58
PE Ratio	-	-	-	14.89	19.60	-
Forward PE	-	208.00	208.00	208.00	208.00	208.00
PS Ratio	1.30	1.38	1.40	1.15	1.02	1.18
PB Ratio	1.12	1.04	0.97	1.21	1.19	1.25
P/TBV Ratio	1.12	1.04	0.97	1.21	1.19	1.25
P/FCF Ratio	-	-	-	10.36	34.42	29.87
P/OCF Ratio	-	-	-	10.32	33.31	29.47
PEG Ratio	-	14.86	14.86	14.86	14.86	14.86
EV/Sales Ratio	0.10	0.19	0.07	0.31	0.31	0.39
EV/EBITDA Ratio	-	-	-	4.56	4.91	-
EV/EBIT Ratio	-	-	-	4.75	5.12	-
EV/FCF Ratio	-4.82	-	-	2.82	10.49	9.97
Debt / Equity Ratio	-	0.00	0.01	0.02	0.03	0.03
Debt / EBITDA Ratio	-	-	-	0.26	0.35	-
Debt / FCF Ratio	-	-	-	0.18	0.85	0.78
Net Debt / Equity Ratio	-1.03	-0.91	-0.91	-0.91	-0.84	-0.89
Net Debt / EBITDA Ratio	18.37	18.74	9.93	-12.55	-11.40	4.46
Net Debt / FCF Ratio	57.21	48.87	17.28	-7.77	-24.38	-21.22
Asset Turnover	0.60	0.60	0.53	0.84	0.87	0.75
Quick Ratio	3.99	7.60	8.08	8.78	9.23	8.27
Current Ratio	4.03	7.70	8.32	9.01	9.46	8.55
Return on Equity (ROE)	-0.69%	-0.78%	-5.21%	8.02%	5.68%	-10.04%
Return on Assets (ROA)	-2.70%	-2.66%	-4.45%	3.44%	3.29%	-8.95%
Return on Invested Capital (ROIC)	-166.88%	-56.62%	-96.81%	42.55%	42.85%	-74.35%
Return on Capital Employed (ROCE)	-6.30%	-5.40%	-8.90%	6.30%	6.30%	-18.10%
Earnings Yield	-0.66%	-0.81%	-5.84%	6.71%	5.10%	-8.81%
FCF Yield	-1.61%	-1.79%	-5.46%	9.65%	2.90%	3.35%
Payout Ratio	-	-	-	131.57%	342.37%	-
Buyback Yield / Dilution	0.13%	0.07%	0.10%	0.15%	0.56%	-0.53%

Updated Jan 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.